• Login
0 Items
Cannin - Cannabis & Hemp Investment Group
  • Home
  • Get Free Trial
  • Cannabis & Hemp News
  • Investment Resources
    • Featured Companies
    • Company Reports
    • Stock Quotes
    • Directory
  • Contact Us
  • Login
Select Page
CURE Pharmaceutical: Should You Buy this Cannabis Biotech Stock?

CURE Pharmaceutical: Should You Buy this Cannabis Biotech Stock?

Cannabis in the News, CBD in the News, CBD Stocks, Finance, Investment Opportunities, marijuana stock, Research, Stock Talk, Technology/Innovations, Trending

Should you buy this cannabis biotech stock CURE Pharmaceutical? CURE Pharmaceutical Holding Corp. (OTC: CURR) focuses on the development and manufacturing of drug formulation and drug delivery technologies in novel dosage forms (thin wafers and thin films). Notably,...
Insomnia Treatment Study using MediPharm Labs CBD50 Product to Proceed to Phase 2

Insomnia Treatment Study using MediPharm Labs CBD50 Product to Proceed to Phase 2

Cannabis in the News, CBD in the News, CBD Stocks, Investment Opportunities, marijuana stock, New Product, Research, Technology/Innovations

Insomnia Treatment Study using MediPharm Labs CBD50 Product to Proceed to Phase 2 with Health Canada Consent — McMaster University researchers using MediPharm Labs’ CBD50 formula and a CBD:THC 10:2 formulation, which has the same cannabinoid ratio as MediPharm...
Entheon Biomedical Announces Sponsorship of a Clinical Study to Assess the Effects of Ketamine

Entheon Biomedical Announces Sponsorship of a Clinical Study to Assess the Effects of Ketamine

Cannabis in the News, Cannabis Law, Psychedelic Stocks, Research

EEG Study to be incorporated into Entheon IQ(TM), developing data-driven treatment algorithms for psychedelic treatments Entheon Biomedical Announces Sponsorship of a Clinical Study to Assess the Effects of Ketamine — Vancouver, British Columbia–(Newsfile...
Revive Therapeutics Provides Update on Psychedelics Clinical Product Pipeline

Revive Therapeutics Provides Update on Psychedelics Clinical Product Pipeline

Cannabis in the News, CBD Stocks, Health, Investment Opportunities, Psychedelic Stocks, Research, Science, Technology/Innovations

Focusing on novel uses, production and delivery forms of psilocybin as a next generation solution for mental illness, substance abuse and neurological disorders Advancing to FDA clinical studies for methamphetamine use disorder and stroke Revive Therapeutics Provides...
Nootropic Mushrooms for Wellness Are on the Rise

Nootropic Mushrooms for Wellness Are on the Rise

Cannabis in the News, Investment Opportunities, Psychedelic Stocks, Research, Science, Wellness

Nootropic Mushrooms for Wellness Are on the Rise and Privy Peach founder launches a new mushroom brand. DENVER, July 29, 2021 /PRNewswire/ — Kim Koehler, Privy Peach CBD brand founder, was recently listed as a Forbes top entrepreneurs to watch, and with good...
Full Spectrum Hemp Extract Chemistry Studies Underway at Colorado State University

Full Spectrum Hemp Extract Chemistry Studies Underway at Colorado State University

Cannabis in the News, CBD in the News, CBD Stocks, Charlotte's Web, Extracts, Health, Hemp, Investment Opportunities, Laboratory Testing, Research

Full Spectrum Hemp Extract Chemistry Studies Underway at Colorado State University’s College of Agricultural Sciences with Charlotte’s Web’s CW Labs Multi-phase research project advances scientific data on how genetics, growing conditions and...
« Older Entries

Already Registered,
Login below to add a listing

Login

 
 
Forgot Password

Search Cannabis and Hemp Stocks

https://aphrihelios.com/

Free Cannabis News & Investment Tips

Delivered to your inbox, Every Sunday

Recent Posts

  • Cannabis Investment Strategies For High Profits September 22, 2021
  • Want to Invest in a Massachusetts Cannabis Cultivation Facility? September 21, 2021
  • 5 Most-Preferred Ways to Consume CBD Effectively September 21, 2021
  • CENTR Brands Corp. Announces Q1’22 473% Record Sales Increase September 20, 2021
  • Why Now Is The Best Time To Invest In Cannabis Stocks September 20, 2021
Top Hemp Stocks to Buy

Cannabis Stock Watchlist

×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
Symbol Last Price % Change

Search for Specific Hemp and Cannabis Stocks

From the Cannin Community

"Cannin sends specific instructions on how to make the trade. They continue to send profitable signals and I love their service. Thanks, Cannin!"

-Mark H.
Vail, Colorado

https://aphrihelios.com/

CanninPlus with Trading Alerts!

Get advance notice of profitable cannabis & hemp stock trades. Use our machine learning algorithm to start profiting from this explosive industry.

GET A FREE TRIAL

$99 / month after 7-day trial. Still unsure? Schedule demo at demo@cannin.com or call 720-254-1374
Top Hemp Stocks to Buy

The Best Cannabis Stocks for 2021

  • Cannin Report Q1 2021 Cannin Report Q2 2021 $99.00 $49.00
  • Cannin Report Q1 2021 Cannin Report Q1 2021 $49.00 $29.00
  • The Cannin Report Q2 2019 - The Hemp Edition The Cannin Report 2020 $49.00 $19.00
  • The Cannin Report Q2 2019 - The Hemp Edition FREE Sample Cannin Report Q1 2020 - Our #1 Stock Pick $9.99 $0.00
  • The Cannin Report Q2 2019 - The Hemp Edition The Cannin Report Q4 2019 $99.00 $29.00

Free Cannabis News & Investment Tips

Delivered to your inbox, Every Sunday

Risk of Prosecution for Marijuana-Related Companies.  If you are considering investing in a company that is connected to the marijuana industry, be aware that marijuana-related companies may be at risk of federal, and perhaps state, criminal prosecution.  The Department of Treasury recently issued guidance noting: “ The Controlled Substances Act (“CSA”) makes it illegal under federal law to manufacture, distribute, or dispense marijuana.  Many states impose and enforce similar prohibitions.  Notwithstanding the federal ban, as of the date of this guidance, 20 states and the District of Columbia have legalized certain marijuana-related activity.”

  • Facebook
  • Twitter
  • Instagram
© 2020 Cannin All Rights Reserved. | Refund | Terms | Privacy | Cannin.com 3000 Lawrence Street #6 Denver, Colorado 80205
CanninBot - Daily Trading Alerts
Terms:
First Week Free, then $39/month. Cancel Anytime.
Invalid Username
Invalid Email
Invalid Password
Password Confirmation Doesn't Match
Have a coupon?
Loading... Invalid Coupon
Authorize.net
Invalid Credit Card Number
Invalid Expiration
Invalid CVC Code
 
Loading... Please fix the errors above
CanninPlus
Terms:
First Week FREE then $99/month. Cancel Anytime.
Invalid Username
Invalid Email
Invalid Password
Password Confirmation Doesn't Match
Have a coupon?
Loading... Invalid Coupon
Authorize.net
Invalid Credit Card Number
Invalid Expiration
Invalid CVC Code
 
Loading... Please fix the errors above